-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, LgTy7HQhpWCm9QU66FNCsbIWaMtS2JtNDNEE1W+jma9y5BlTpybbaWdBvPJd7ayo SXRaur30SV/LBfiPlhrU4Q== 0001104659-07-003786.txt : 20070123 0001104659-07-003786.hdr.sgml : 20070123 20070123060248 ACCESSION NUMBER: 0001104659-07-003786 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20070123 DATE AS OF CHANGE: 20070123 GROUP MEMBERS: PERSHING SQUARE GP, LLC GROUP MEMBERS: PS MANAGEMENT GP, LLC GROUP MEMBERS: WILLIAM A ACKMAN SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: CERIDIAN CORP /DE/ CENTRAL INDEX KEY: 0001124887 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MANAGEMENT CONSULTING SERVICES [8742] IRS NUMBER: 411981625 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-61527 FILM NUMBER: 07544598 BUSINESS ADDRESS: STREET 1: 3311 E OLD SHAKOPEE RD CITY: MINNEAPOLIS STATE: MN ZIP: 55425 BUSINESS PHONE: 9528538100 MAIL ADDRESS: STREET 1: 3311 EAST OLD SHAKOPEE RD CITY: MINNEAPOLIS STATE: MN ZIP: 55425 FORMER COMPANY: FORMER CONFORMED NAME: NEW CERIDIAN CORP DATE OF NAME CHANGE: 20000927 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Pershing Square Capital Management, L.P. CENTRAL INDEX KEY: 0001336528 IRS NUMBER: 383694136 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A BUSINESS ADDRESS: STREET 1: 888 SEVENTH AVENUE STREET 2: 29TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: 212-813-3700 MAIL ADDRESS: STREET 1: 888 SEVENTH AVENUE STREET 2: 29TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 SC 13D/A 1 a07-2321_1sc13da.htm AMENDMENT

 

 

UNITED STATES

OMB APPROVAL

 

SECURITIES AND EXCHANGE
COMMISSION

OMB Number:
3235-0145

 

Washington, D.C. 20549

Expires: February 28, 2009

 

SCHEDULE 13D

Estimated average burden hours per response. . 14.5

Under the Securities Exchange Act of 1934
(Amendment No. 1)*

Ceridian Corporation

(Name of Issuer)

 

Common Stock, par value $0.01 per share

(Title of Class of Securities)

 

156779100

(CUSIP Number)

 

Roy J. Katzovicz
Pershing Square Capital Management, L.P.
888 Seventh Avenue, 29th Floor
New York, NY 10019
212-813-3700

with a copy to:

Alan J. Sinsheimer

Sullivan & Cromwell LLP

125 Broad Street

New York, NY 10004-2498

212-558-4000

and

Janet T. Geldzahler

Sullivan & Cromwell LLP

1701 Pennsylvania Avenue, N.W.

Washington, D.C. 20006-5805

202-956-7500

(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)

 

January 23, 2007

(Date of Event which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Sections 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box:  o

NOTE: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See ss. 240.13d-7 for other parties to whom copies are to be sent.

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).




 

CUSIP No. 156779100

 

 

1.

Name of Reporting Person. I.R.S. Identification No. of above person (entities only)


Pershing Square Capital Management, L.P.

 

 

2.

Check the Appropriate Box if a Member of a Group (See Instructions)

 

 

(a)

 o

 

 

(b)

 x

 

 

3.

SEC Use Only

 

 

4.

Source of Funds (See Instructions)
OO

 

 

5.

Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)     o

 

 

6.

Citizenship or Place of Organization
Delaware

 

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With

7.

Sole Voting Power
-0-

 

8.

Shared Voting Power
15,724,334

 

9.

Sole Dispositive Power
-0-

 

10.

Shared Dispositive Power
15,724,334

 

 

11.

Aggregate Amount Beneficially Owned by Each Reporting Person
15,724,334

 

 

12.

Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)   o

 

 

13.

Percent of Class Represented by Amount in Row (11)
11.3%
1

 

 

14.

Type of Reporting Person (See Instructions)
IA


1        Calculated based on 139,124,108 shares of the common stock, par value $0.01, of Ceridian Corporation outstanding as of October 31, 2006, as reported in Ceridian Corporation’s quarterly report on Form 10-Q for the quarterly period ended September 30, 2006.




 

CUSIP No. 156779100

 

 

1.

Name of Reporting Person. I.R.S. Identification No. of above person (entities only)


PS Management GP, LLC

 

 

2.

Check the Appropriate Box if a Member of a Group (See Instructions)

 

 

(a)

 o

 

 

(b)

 x

 

 

3.

SEC Use Only

 

 

4.

Source of Funds (See Instructions)
OO

 

 

5.

Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)     o

 

 

6.

Citizenship or Place of Organization
Delaware

 

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With

7.

Sole Voting Power
-0-

 

8.

Shared Voting Power
15,724,334

 

9.

Sole Dispositive Power
-0-

 

10.

Shared Dispositive Power
15,724,334

 

 

11.

Aggregate Amount Beneficially Owned by Each Reporting Person
15,724,334

 

 

12.

Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)   o

 

 

13.

Percent of Class Represented by Amount in Row (11)
11.3%
2

 

 

14.

Type of Reporting Person (See Instructions)
OO


2    Calculated based on 139,124,108 shares of the common stock, par value $0.01, of Ceridian Corporation outstanding as of October 31, 2006, as reported in Ceridian Corporation’s quarterly report on Form 10-Q for the quarterly period ended September 30, 2006.




 

CUSIP No. 156779100

 

 

1.

Name of Reporting Person. I.R.S. Identification No. of above person (entities only)


Pershing Square GP, LLC

 

 

2.

Check the Appropriate Box if a Member of a Group (See Instructions)

 

 

(a)

 o

 

 

(b)

 x

 

 

3.

SEC Use Only

 

 

4.

Source of Funds (See Instructions)
OO

 

 

5.

Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)     o

 

 

6.

Citizenship or Place of Organization
Delaware

 

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With

7.

Sole Voting Power
-0-

 

8.

Shared Voting Power
15,724,334

 

9.

Sole Dispositive Power
-0-

 

10.

Shared Dispositive Power
15,724,334

 

 

11.

Aggregate Amount Beneficially Owned by Each Reporting Person
15,724,334

 

 

12.

Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)   o

 

 

13.

Percent of Class Represented by Amount in Row (11)
11.3%
3

 

 

14.

Type of Reporting Person (See Instructions)
IA


3    Calculated based on 139,124,108 shares of the common stock, par value $0.01, of Ceridian Corporation outstanding as of October 31, 2006, as reported in Ceridian Corporation’s quarterly report on Form 10-Q for the quarterly period ended September 30, 2006.




 

CUSIP No. 156779100

 

 

1.

Name of Reporting Person. I.R.S. Identification No. of above person (entities only)


William A. Ackman

 

 

2.

Check the Appropriate Box if a Member of a Group (See Instructions)

 

 

(a)

 o

 

 

(b)

 x

 

 

3.

SEC Use Only

 

 

4.

Source of Funds (See Instructions)
OO

 

 

5.

Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)     o

 

 

6.

Citizenship or Place of Organization
United States

 

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With

7.

Sole Voting Power
-0-

 

8.

Shared Voting Power
15,724,334

 

9.

Sole Dispositive Power
-0-

 

10.

Shared Dispositive Power
15,724,334

 

 

11.

Aggregate Amount Beneficially Owned by Each Reporting Person
15,724,334

 

 

12.

Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)   o

 

 

13.

Percent of Class Represented by Amount in Row (11)
11.3%
3

 

 

14.

Type of Reporting Person (See Instructions)
IN


4    Calculated based on 139,124,108 shares of the common stock, par value $0.01, of Ceridian Corporation outstanding as of October 31, 2006, as reported in Ceridian Corporation’s quarterly report on Form 10-Q for the quarterly period ended September 30, 2006.




Item 1.    Security and Issuer.

This amendment No. 1 amends and supplements the statement on Schedule 13D (the “Original Schedule 13D’’), filed on January 18, 2007 by Pershing Square Capital Management, L.P., a Delaware limited partnership (“Pershing Square”), PS Management GP, LLC, a Delaware limited liability company, Pershing Square GP, LLC, a Delaware limited liability company, and William A. Ackman, a citizen of the United States of America (collectively, the “Reporting Persons”), relating to the common stock, par value $0.01 per share, of Ceridian Corporation, a Delaware corporation (the “Issuer”).  The address of the principal executive offices of the Issuer is 3311 East Old Shakopee Road, Minneapolis, Minnesota 55425.

Item 4.    Purpose of Transaction.

Item 4 is hereby supplemented as follows:

On January 23, 2007, representatives of Pershing Square, L.P., a Delaware limited partnership, Pershing Square II, L.P., a Delaware limited partnership, and Pershing Square International, Ltd., a Cayman Islands exempted company (collectively, the “Stockholders”), which are investment funds affiliated with the Reporting Persons, delivered a notice (the “Notice”) to Mr. Gary M. Nelson, the Executive Vice President, Chief Administrative Officer, General Counsel and Corporate Secretary of the Issuer, in accordance with Article II, Section 13 of the Bylaws of the Issuer.  In the Notice, the Stockholders notify the Issuer that the Stockholders propose to nominate the following persons for election to the Issuer’s Board of Directors at the Issuer’s 2007 annual meeting of stockholders: William A. Ackman, Michael L. Ashner, John D. Barfitt, Harald Einsmann, Robert J. Levenson, Michael E. Porter, Gregory A. Pratt and Alan Schwartz (collectively, the “Nominees’’). The biographical information on each of the Nominees is available in the additional definitive proxy soliciting materials filed by the Stockholders with the Securities and Exchange Commission on January 23, 2007.

Item 5.                          Interest in Securities of the Issuer.

Item 5(c) is hereby amended and restated in its entirety as follows:

(c)             See trading data attached hereto as Exhibit 99.1. Exhibit 99.1 is incorporated by reference into this Item 5(c) as if restated in full.

Except as set forth in Exhibit 99.1 attached hereto, within the last 60 days, no other transactions in shares of the Common Stock were effected by any Reporting Person.

Item 7.                          Material to be Filed as Exhibits.

Item 7 is hereby supplemented by adding the following exhibit:

Exhibit 99.1

 

Required trading data of the transactions in the Common Stock.

 




SIGNATURES

After reasonable inquiry and to the best of our knowledge and belief, the undersigned certify that the information set forth in this statement is true, complete and correct.

Dated:  January 23, 2007

PERSHING SQUARE CAPITAL MANAGEMENT, L.P.

 

By: PS Management GP, LLC,

 

its General Partner

 

 

 

By:

/s/ William A. Ackman

 

 

 

William A. Ackman

 

 

Managing Member

 

 

 

 

PS MANAGEMENT GP, LLC

 

 

 

By:

/s/ William A. Ackman

 

 

 

William A. Ackman

 

 

Managing Member

 

 

 

 

PERSHING SQUARE GP, LLC

 

 

 

 

 

By:

/s/ William A. Ackman

 

 

 

 

 

 

William A. Ackman

 

 

Managing Member

 

 

 

 

 

 

 

/s/ William A. Ackman

 

 

WILLIAM A. ACKMAN

 




 

EXHIBIT INDEX

Exhibit

 

 

Description

 

99.1

 

Required trading data of the transactions in the Common Stock.

 



EX-99.1 2 a07-2321_1ex99d1.htm EX-99.1

 

EXHIBIT 99.1

TRAN
CODE

 

SECURITY

 

TRADE
DATE

 

SETTLE
DATE

 

QUANTITY

 

UNIT
COST

 

TRADE
AMOUNT

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

PERSHING SQUARE INTERNATIONAL, LTD.   

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

BUY

 

CERIDIAN CORPORATION

 

11/20/2006

 

11/24/2006

 

 

56,133

 

$

24.75

 

$

1,389,011

 

BUY

 

CERIDIAN CORPORATION

 

11/21/2006

 

11/27/2006

 

 

11,736

 

$

24.76

 

$

290,582

 

BUY

 

CERIDIAN CORPORATION

 

11/21/2006

 

11/27/2006

 

 

13,985

 

$

24.71

 

$

345,499

 

BUY

 

CERIDIAN CORPORATION

 

11/27/2006

 

11/30/2006

 

 

93,330

 

$

24.43

 

$

2,280,192

 

BUY

 

CERIDIAN CORPORATION

 

11/27/2006

 

11/30/2006

 

 

14,073

 

$

24.44

 

$

343,944

 

BUY

 

CERIDIAN CORPORATION

 

11/27/2006

 

11/30/2006

 

 

14,636

 

$

24.44

 

$

357,704

 

BUY

 

CERIDIAN CORPORATION

 

11/28/2006

 

12/1/2006  

 

 

50,703

 

$

24.29

 

$

1,231,708

 

BUY

 

CERIDIAN CORPORATION

 

11/28/2006

 

12/1/2006  

 

 

18,069

 

$

24.26

 

$

438,264

 

BUY

 

CERIDIAN CORPORATION

 

11/28/2006

 

12/1/2006  

 

 

42,218

 

$

24.30

 

$

1,026,108

 

BUY

 

CERIDIAN CORPORATION

 

11/29/2006

 

12/4/2006  

 

 

44,153

 

$

24.55

 

$

1,084,124

 

BUY

 

CERIDIAN CORPORATION

 

11/29/2006

 

12/4/2006  

 

 

14,073

 

$

24.22

 

$

340,848

 

BUY

 

CERIDIAN CORPORATION

 

11/29/2006

 

12/4/2006  

 

 

111,918

 

$

24.37

 

$

2,726,994

 

BUY

 

CERIDIAN CORPORATION

 

11/30/2006

 

12/5/2006  

 

 

132,723

 

$

24.45

 

$

3,245,250

 

SELL*

 

CERIDIAN CORPORATION

 

12/1/2006  

 

12/5/2006  

 

 

(146,425

)

$

24.51

 

$

3,588,877

 

BUY

 

CERIDIAN CORPORATION

 

12/1/2006  

 

12/6/2006  

 

 

13,667

 

$

24.57

 

$

335,798

 

BUY

 

CERIDIAN CORPORATION

 

12/1/2006  

 

12/6/2006  

 

 

115,336

 

$

24.56

 

$

2,832,998

 

BUY

 

CERIDIAN CORPORATION

 

12/4/2006  

 

12/6/2006  

 

 

13,667

 

$

24.94

 

$

340,855

 

BUY

 

CERIDIAN CORPORATION

 

12/4/2006  

 

12/6/2006  

 

 

1,476

 

$

24.62

 

$

36,337

 

BUY

 

CERIDIAN CORPORATION

 

12/4/2006  

 

12/6/2006  

 

 

42,611

 

$

24.82

 

$

1,057,520

 

BUY

 

CERIDIAN CORPORATION

 

12/5/2006  

 

12/8/2006  

 

 

104,520

 

$

25.19

 

$

2,632,671

 

BUY

 

CERIDIAN CORPORATION

 

12/5/2006  

 

12/8/2006  

 

 

27,347

 

$

25.08

 

$

685,931

 

BUY

 

CERIDIAN CORPORATION

 

12/6/2006  

 

12/11/2006

 

 

37,928

 

$

25.38

 

$

962,506

 

BUY

 

CERIDIAN CORPORATION

 

12/6/2006  

 

12/11/2006

 

 

109,304

 

$

25.45

 

$

2,782,202

 

BUY

 

CERIDIAN CORPORATION

 

12/6/2006  

 

12/11/2006

 

 

127,831

 

$

25.50

 

$

3,529,716

 

BUY

 

CERIDIAN CORPORATION

 

12/7/2006  

 

12/12/2006

 

 

41,005

 

$

25.57

 

$

1,048,428

 

BUY

 

CERIDIAN CORPORATION

 

12/7/2006  

 

12/12/2006

 

 

142,150

 

$

25.58

 

$

3,636,126

 

BUY

 

CERIDIAN CORPORATION

 

12/8/2006  

 

12/13/2006

 

 

1,312

 

$

25.40

 

$

33,325

 

BUY

 

CERIDIAN CORPORATION

 

12/8/2006  

 

12/13/2006

 

 

116,799

 

$

25.55

 

$

2,983,759

 

BUY

 

CERIDIAN CORPORATION

 

12/11/2006

 

12/14/2006

 

 

27,312

 

$

25.75

 

$

703,216

 

BUY

 

CERIDIAN CORPORATION

 

12/11/2006

 

12/14/2006

 

 

224,399

 

$

25.73

 

$

5,774,011

 

BUY

 

CERIDIAN CORPORATION

 

12/12/2006

 

12/15/2006

 

 

177,807

 

$

25.78

 

$

4,583,936

 

BUY

 

CERIDIAN CORPORATION

 

12/12/2006

 

12/15/2006

 

 

142,246

 

$

25.79

 

$

3,669,236

 

BUY

 

CERIDIAN CORPORATION

 

12/13/2006

 

12/18/2006

 

 

73,139

 

$

25.74

 

$

1,882,408

 

BUY

 

CERIDIAN CORPORATION

 

12/13/2006

 

12/18/2006

 

 

54,694

 

$

25.78

 

$

1,409,875

 

BUY

 

CERIDIAN CORPORATION

 

12/13/2006

 

12/18/2006

 

 

120,545

 

$

25.83

 

$

3,113,448

 

BUY

 

CERIDIAN CORPORATION

 

12/13/2006

 

12/18/2006

 

 

2,680

 

$

25.83

 

$

69,226

 

BUY

 

CERIDIAN CORPORATION

 

12/14/2006

 

12/19/2006

 

 

43,257

 

$

26.21

 

$

1,133,788

 

BUY

 

CERIDIAN CORPORATION

 

12/14/2006

 

12/19/2006

 

 

27,333

 

$

26.21

 

$

716,330

 

BUY

 

CERIDIAN CORPORATION

 

12/14/2006

 

12/19/2006

 

 

109,332

 

$

26.21

 

$

2,865,384

 

BUY

 

CERIDIAN CORPORATION

 

12/18/2006

 

12/21/2006

 

 

2,845

 

$

26.19

 

$

74,500

 

BUY

 

CERIDIAN CORPORATION

 

12/18/2006

 

12/21/2006

 

 

32,490

 

$

26.37

 

$

856,755

 

BUY

 

CERIDIAN CORPORATION

 

12/18/2006

 

12/21/2006

 

 

27,349

 

$

26.24

 

$

717,638

 

BUY*

 

CERIDIAN CORPORATION

 

1/1/2007    

 

1/4/2007    

 

 

142,447

 

$

27.98

 

$

3,985,667

 

 

*                    For portfolio rebalancing purposes, this transaction represents a purchase or sale among one or more Pershing Square funds.

1




 

TRAN
CODE

 

SECURITY

 

TRADE
DATE

 

SETTLE
DATE

 

QUANTITY

 

UNIT
COST

 

TRADE
AMOUNT

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

PERSHING SQUARE, L.P.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

BUY

 

CERIDIAN CORPORATION

 

11/20/2006

 

11/24/2006

 

 

15,250

 

$

24.60

 

$

375,222

 

BUY

 

CERIDIAN CORPORATION

 

11/20/2006

 

11/24/2006

 

 

42,954

 

$

24.74

 

$

1,062,897

 

BUY

 

CERIDIAN CORPORATION

 

11/21/2006

 

11/27/2006

 

 

10,762

 

$

24.70

 

$

265,875

 

BUY

 

CERIDIAN CORPORATION

 

11/21/2006

 

11/27/2006

 

 

36,232

 

$

24.76

 

$

897,101

 

BUY

 

CERIDIAN CORPORATION

 

11/27/2006

 

11/30/2006

 

 

115,670

 

$

24.43

 

$

2,825,992

 

BUY

 

CERIDIAN CORPORATION

 

11/27/2006

 

11/30/2006

 

 

10,927

 

$

24.44

 

$

267,056

 

BUY

 

CERIDIAN CORPORATION

 

11/27/2006

 

11/30/2006

 

 

11,364

 

$

24.44

 

$

277,736

 

BUY

 

CERIDIAN CORPORATION

 

11/28/2006

 

12/1/2006  

 

 

39,371

 

$

24.29

 

$

956,424

 

BUY

 

CERIDIAN CORPORATION

 

11/28/2006

 

12/1/2006  

 

 

14,031

 

$

24.26

 

$

340,322

 

BUY

 

CERIDIAN CORPORATION

 

11/28/2006

 

12/1/2006  

 

 

32,782

 

$

24.30

 

$

796,767

 

BUY

 

CERIDIAN CORPORATION

 

11/29/2006

 

12/4/2006  

 

 

34,284

 

$

24.55

 

$

841,802

 

BUY

 

CERIDIAN CORPORATION

 

11/29/2006

 

12/4/2006  

 

 

10,927

 

$

24.22

 

$

264,652

 

BUY

 

CERIDIAN CORPORATION

 

11/29/2006

 

12/4/2006  

 

 

86,904

 

$

24.37

 

$

2,117,503

 

BUY

 

CERIDIAN CORPORATION

 

11/30/2006

 

12/5/2006  

 

 

80,000

 

$

24.45

 

$

1,956,104

 

BUY*

 

CERIDIAN CORPORATION

 

12/1/2006  

 

12/5/2006  

 

 

146,134

 

$

24.51

 

$

3,581,744

 

BUY

 

CERIDIAN CORPORATION

 

12/1/2006  

 

12/6/2006  

 

 

11,100

 

$

24.57

 

$

272,727

 

BUY

 

CERIDIAN CORPORATION

 

12/1/2006  

 

12/6/2006  

 

 

93,674

 

$

24.56

 

$

2,300,914

 

BUY

 

CERIDIAN CORPORATION

 

12/4/2006  

 

12/6/2006  

 

 

11,100

 

$

24.94

 

$

276,834

 

BUY

 

CERIDIAN CORPORATION

 

12/4/2006  

 

12/6/2006  

 

 

1,199

 

$

24.62

 

$

29,518

 

BUY

 

CERIDIAN CORPORATION

 

12/4/2006  

 

12/6/2006  

 

 

34,608

 

$

24.82

 

$

858,901

 

BUY

 

CERIDIAN CORPORATION

 

12/5/2006  

 

12/8/2006  

 

 

84,799

 

$

25.19

 

$

2,135,934

 

BUY

 

CERIDIAN CORPORATION

 

12/5/2006  

 

12/8/2006  

 

 

22,187

 

$

25.08

 

$

556,505

 

BUY

 

CERIDIAN CORPORATION

 

12/6/2006  

 

12/11/2006

 

 

30,823

 

$

25.38

 

$

782,201

 

BUY

 

CERIDIAN CORPORATION

 

12/6/2006  

 

12/11/2006

 

 

88,827

 

$

25.45

 

$

2,260,985

 

BUY

 

CERIDIAN CORPORATION

 

12/6/2006  

 

12/11/2006

 

 

103,883

 

$

25.50

 

$

2,649,037

 

BUY

 

CERIDIAN CORPORATION

 

12/7/2006  

 

12/12/2006

 

 

33,295

 

$

25.57

 

$

851,297

 

BUY

 

CERIDIAN CORPORATION

 

12/7/2006  

 

12/12/2006

 

 

115,422

 

$

25.58

 

$

2,952,437

 

BUY

 

CERIDIAN CORPORATION

 

12/8/2006  

 

12/13/2006

 

 

1,066

 

$

25.40

 

$

27,076

 

BUY

 

CERIDIAN CORPORATION

 

12/8/2006  

 

12/13/2006

 

 

94,932

 

$

25.55

 

$

2,425,142

 

BUY

 

CERIDIAN CORPORATION

 

12/11/2006

 

12/14/2006

 

 

22,221

 

$

25.75

 

$

572,135

 

BUY

 

CERIDIAN CORPORATION

 

12/11/2006

 

12/14/2006

 

 

182,564

 

$

25.73

 

$

4,697,554

 

BUY

 

CERIDIAN CORPORATION

 

12/12/2006

 

12/15/2006

 

 

144,165

 

$

25.78

 

$

3,716,631

 

BUY

 

CERIDIAN CORPORATION

 

12/12/2006

 

12/15/2006

 

 

115,332

 

$

25.79

 

$

2,974,989

 

BUY

 

CERIDIAN CORPORATION

 

12/13/2006

 

12/18/2006

 

 

59,339

 

$

25.74

 

$

1,527,232

 

BUY

 

CERIDIAN CORPORATION

 

12/13/2006

 

12/18/2006

 

 

44,374

 

$

25.78

 

$

1,143,851

 

BUY

 

CERIDIAN CORPORATION

 

12/13/2006

 

12/18/2006

 

 

97,800

 

$

25.83

 

$

2,525,988

 

BUY

 

CERIDIAN CORPORATION

 

12/13/2006

 

12/18/2006

 

 

2,174

 

$

25.83

 

$

56,156

 

BUY

 

CERIDIAN CORPORATION

 

12/14/2006

 

12/19/2006

 

 

35,136

 

$

26.21

 

$

920,932

 

BUY

 

CERIDIAN CORPORATION

 

12/14/2006

 

12/19/2006

 

 

22,201

 

$

26.21

 

$

581,833

 

BUY

 

CERIDIAN CORPORATION

 

12/14/2006

 

12/19/2006

 

 

88,804

 

$

26.21

 

$

2,327,384

 

BUY

 

CERIDIAN CORPORATION

 

12/18/2006

 

12/21/2006

 

 

2,307

 

$

26.19

 

$

60,412

 

BUY

 

CERIDIAN CORPORATION

 

12/18/2006

 

12/21/2006

 

 

26,357

 

$

26.37

 

$

695,029

 

BUY

 

CERIDIAN CORPORATION

 

12/18/2006

 

12/21/2006

 

 

22,186

 

$

26.24

 

$

582,161

 

SELL*

 

CERIDIAN CORPORATION

 

1/1/2007    

 

1/4/2007    

 

 

(82,031

)

$

27.98

 

$

(2,295,227

)

 

*                    For portfolio rebalancing purposes, this transaction represents a purchase or sale among one or more Pershing Square funds.

2




 

TRAN
CODE

 

SECURITY

 

TRADE
DATE

 

SETTLE
DATE

 

QUANTITY

 

UNIT
COST

 

TRADE
AMOUNT

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

PERSHING SQUARE II, L.P.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

BUY

 

CERIDIAN CORPORATION

 

11/20/2006

 

11/24/2006

 

 

850

 

$

24.60

 

$

20,914

 

BUY

 

CERIDIAN CORPORATION

 

11/20/2006

 

11/24/2006

 

 

913

 

$

24.75

 

$

22,592

 

BUY

 

CERIDIAN CORPORATION

 

11/21/2006

 

11/27/2006

 

 

253

 

$

24.70

 

$

6,250

 

BUY

 

CERIDIAN CORPORATION

 

11/21/2006

 

11/27/2006

 

 

11,632

 

$

24.76

 

$

288,007

 

BUY*

 

CERIDIAN CORPORATION

 

12/1/2006  

 

12/5/2006  

 

 

291

 

$

24.51

 

$

7,132

 

BUY

 

CERIDIAN CORPORATION

 

12/1/2006  

 

12/6/2006  

 

 

233

 

$

24.57

 

$

5,725

 

BUY

 

CERIDIAN CORPORATION

 

12/1/2006  

 

12/6/2006  

 

 

1,969

 

$

24.56

 

$

48,365

 

BUY

 

CERIDIAN CORPORATION

 

12/4/2006  

 

12/6/2006  

 

 

233

 

$

24.94

 

$

5,811

 

BUY

 

CERIDIAN CORPORATION

 

12/4/2006  

 

12/6/2006  

 

 

25

 

$

24.60

 

$

615

 

BUY

 

CERIDIAN CORPORATION

 

12/4/2006  

 

12/6/2006  

 

 

728

 

$

24.82

 

$

18,067

 

BUY

 

CERIDIAN CORPORATION

 

12/5/2006  

 

12/8/2006  

 

 

1,781

 

$

25.19

 

$

44,860

 

BUY

 

CERIDIAN CORPORATION

 

12/5/2006  

 

12/8/2006  

 

 

466

 

$

25.08

 

$

11,688

 

BUY

 

CERIDIAN CORPORATION

 

12/6/2006  

 

12/11/2006

 

 

649

 

$

25.38

 

$

16,470

 

BUY

 

CERIDIAN CORPORATION

 

12/6/2006  

 

12/11/2006

 

 

1,869

 

$

25.45

 

$

47,573

 

BUY

 

CERIDIAN CORPORATION

 

12/6/2006  

 

12/11/2006

 

 

2,186

 

$

25.50

 

$

55,743

 

BUY

 

CERIDIAN CORPORATION

 

12/7/2006  

 

12/12/2006

 

 

700

 

$

25.57

 

$

17,898

 

BUY

 

CERIDIAN CORPORATION

 

12/7/2006  

 

12/12/2006

 

 

2,428

 

$

25.58

 

$

62,107

 

BUY

 

CERIDIAN CORPORATION

 

12/8/2006  

 

12/13/2006

 

 

22

 

$

25.40

 

$

559

 

BUY

 

CERIDIAN CORPORATION

 

12/8/2006  

 

12/13/2006

 

 

1,997

 

$

25.55

 

$

51,016

 

BUY

 

CERIDIAN CORPORATION

 

12/11/2006

 

12/14/2006

 

 

467

 

$

25.75

 

$

12,024

 

BUY

 

CERIDIAN CORPORATION

 

12/11/2006

 

12/14/2006

 

 

3,837

 

$

25.73

 

$

98,730

 

BUY

 

CERIDIAN CORPORATION

 

12/12/2006

 

12/15/2006

 

 

3,028

 

$

25.78

 

$

78,063

 

BUY

 

CERIDIAN CORPORATION

 

12/12/2006

 

12/15/2006

 

 

2,422

 

$

25.79

 

$

62,475

 

BUY

 

CERIDIAN CORPORATION

 

12/13/2006

 

12/18/2006

 

 

1,247

 

$

25.74

 

$

32,095

 

BUY

 

CERIDIAN CORPORATION

 

12/13/2006

 

12/18/2006

 

 

932

 

$

25.78

 

$

24,025

 

BUY

 

CERIDIAN CORPORATION

 

12/13/2006

 

12/18/2006

 

 

2,055

 

$

25.83

 

$

53,077

 

BUY

 

CERIDIAN CORPORATION

 

12/13/2006

 

12/18/2006

 

 

46

 

$

25.83

 

$

1,188

 

BUY

 

CERIDIAN CORPORATION

 

12/14/2006

 

12/19/2006

 

 

738

 

$

26.21

 

$

19,343

 

BUY

 

CERIDIAN CORPORATION

 

12/14/2006

 

12/19/2006

 

 

466

 

$

26.21

 

$

12,213

 

BUY

 

CERIDIAN CORPORATION

 

12/14/2006

 

12/19/2006

 

 

1,864

 

$

26.21

 

$

48,852

 

BUY

 

CERIDIAN CORPORATION

 

12/18/2006

 

12/21/2006

 

 

48

 

$

26.19

 

$

1,257

 

BUY

 

CERIDIAN CORPORATION

 

12/18/2006

 

12/21/2006

 

 

553

 

$

26.37

 

$

14,582

 

BUY

 

CERIDIAN CORPORATION

 

12/18/2006

 

12/21/2006

 

 

465

 

$

26.24

 

$

12,202

 

SELL*

 

CERIDIAN CORPORATION

 

1/1/2007    

 

1/4/2007    

 

 

(60,416

)

$

27.98

 

$

(1,690,439

)

 

*                    For portfolio rebalancing purposes, this transaction represents a purchase or sale among one or more Pershing Square funds.

3



-----END PRIVACY-ENHANCED MESSAGE-----